Cas:27721-59-1 cyclopent-3-en-1-amine manufacturer & supplier

We serve Chemical Name:cyclopent-3-en-1-amine CAS:27721-59-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

cyclopent-3-en-1-amine

Chemical Name:cyclopent-3-en-1-amine
CAS.NO:27721-59-1
Synonyms:3-Cyclopenten-1-ylamin;cyclopent-3-enylamine;cyclopent-3-ene-1-ylamine;(3-cyclopenten-1-yl)amine;4-amino-1-cyclopentene;3-Cyclopenten-1-amine
Molecular Formula:C5H9N
Molecular Weight:83.13170
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:26.02000
Exact Mass:83.07350
LogP:1.36400

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Cyclopenten-1-ylamin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Cyclopenten-1-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Cyclopenten-1-amine Use and application,3-Cyclopenten-1-amine technical grade,usp/ep/jp grade.


Related News: The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. cyclopent-3-en-1-amine manufacturer The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. cyclopent-3-en-1-amine supplier Like other countries in Southeast Asia, Indonesia depends heavily on Chinese tourism. On Thursday alone, 10,000 Chinese tourists canceled their trips to Bali, according to one industry association. cyclopent-3-en-1-amine vendor Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. cyclopent-3-en-1-amine factory Two sources familiar with the situation told Reuters that the agency had cleared about 10 million doses.